Avantor, Inc.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40009565

Informations générales

Localisation

United States of America

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

03/07/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Avantor, Inc. commits to reduce absolute scope 1 and 2 GHG emissions 50% by 2030 from a 2020 base year. Avantor also commits to reduce absolute scope 3 GHG emissions 25% within the same timeframe. Avantor further commits to reduce absolute scope 3 GHG emissions from use of sold products for sold fossil fuels 42% within the same timeframe.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

US05352A1007

Source : Science Based Targets initiative | Données publiques